---
date: "2024-01-13 06:58:44" # 2021-07-14
title: "Exelon (NASDAQ:EXC) Rating Downgraded to Sell by StockNews.com"
# image: "images/plots/{{titleSlag}}.png"
author: "justin-guese"
draft: false
---
tickers: <a href='https://finance.yahoo.com/quote/EXC' target='_blank'>EXC</a>, <a href='https://finance.yahoo.com/quote/STT' target='_blank'>STT</a>, <a href='https://finance.yahoo.com/quote/BN' target='_blank'>BN</a> 

source: <a href='https://www.defenseworld.net/2024/01/13/exelon-nasdaqexc-rating-lowered-to-sell-at-stocknews-com.html' target='_blank'>Stocknews.com</a>

#### tickers affected by this

| ticker | polarity | why? |
|------------|------------|------------|
| EXC | positively | Based on the downgrade and negative reports from multiple analysts, it is likely that the stock price of EXC will be affected negatively rather than positively. |
| STT | positively | In this context, it is not mentioned that the article is about the ticker STT. Therefore, I cannot provide a specific reason why STT would be affected positively. |
| BN | positively | Based on the information provided, it is not possible to say how the ticker BN would be affected positively by the article since BN is not mentioned in the article. Additional information about BN would be needed to provide an accurate response. |



#### our strategies and bots using these tickers

None so far...

## summary

# Exelon Downgraded to Sell by StockNews.com

**Posted on January 13, 2024**

Exelon (NASDAQ:EXC) has been downgraded from a "hold" rating to a "sell" rating by analysts at StockNews.com. This downgrade comes as other equities analysts have also issued negative reports about the stock. Morgan Stanley lowered their rating from "overweight" to "equal weight" and decreased the target price from $45.00 to $38.00, while UBS Group lowered their rating from "buy" to "neutral" and reduced the target price from $47.00 to $37.00. Mizuho, on the other hand, raised their rating from "neutral" to "buy" and increased the target price from $36.00 to $39.00, and Royal Bank of Canada lowered their target price from $45.00 to $38.00 and maintained a "sector perform" rating. JPMorgan Chase & Co. also downgraded Exelon from "overweight" to "neutral" and set a $41.00 price objective. Overall, two research analysts have rated the stock as "sell," seven as "hold," and four as "buy." MarketBeat.com data shows that the stock currently has a consensus rating of "Hold" and a consensus target price of $40.73.

Shares of Exelon opened at $36.07 on Thursday, down 0.4%. The stock has a 12-month low of $34.05 and a 12-month high of $43.71. Exelon's 50-day moving average price is $37.76, and its 200-day moving average price is $39.37. The company has a quick ratio of 0.77, a current ratio of 0.85, and a debt-to-equity ratio of 1.56. With a market cap of $35.91 billion, Exelon has a price-to-earnings (P/E) ratio of 16.86, a price-to-earnings-to-growth (PEG) ratio of 2.69, and a beta of 0.54.

In its last earnings results issued on November 2, 2023, Exelon reported earnings per share (EPS) of $0.67 for the quarter, missing the consensus estimate of $0.68 by ($0.01). The company generated revenue of $5.98 billion during the quarter, compared to the consensus estimate of $4.96 billion. Exelon's net margin was 10.20%, and its return on equity was 8.81%. Analysts forecast that Exelon will post EPS of 2.36 for the current fiscal year.

Several hedge funds and institutional investors have recently added or reduced their stakes in Exelon. Lazard Asset Management LLC increased its holdings by 133.2% in the second quarter and now owns 17,371,666 shares of the company's stock valued at $707,721,000. T. Rowe Price Investment Management Inc. acquired a new position in the fourth quarter valued at about $413,260,000. Norges Bank also acquired a new position in the fourth quarter valued at about $264,477,000. BROOKFIELD Corp ON increased its holdings by 1,558.6% in the second quarter and now owns 3,957,683 shares of the company's stock, valued at $161,236,000. State Street Corp increased its holdings by 5.6% in the first quarter and now owns 62,018,881 shares of the company's stock, valued at $2,597,969,000. Overall, approximately 81.38% of the stock is owned by hedge funds and institutional investors.

Exelon Corporation operates in the energy distribution and transmission businesses in the United States and Canada. The company purchases and sells electricity and natural gas, as well as distributes them to retail customers.